Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors

ABSTRACT:

SUBMITTER: Wu Y 

PROVIDER: S-EPMC12389332 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature